These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 17381400)
1. Aerosolized ceftazidime prophylaxis against ventilator-associated pneumonia in high-risk trauma patients: results of a double-blind randomized study. Claridge JA; Edwards NM; Swanson J; Fabian TC; Weinberg JA; Wood C; Croce MA Surg Infect (Larchmt); 2007 Feb; 8(1):83-90. PubMed ID: 17381400 [TBL] [Abstract][Full Text] [Related]
2. Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients. Wood GC; Boucher BA; Croce MA; Hanes SD; Herring VL; Fabian TC Pharmacotherapy; 2002 Aug; 22(8):972-82. PubMed ID: 12173800 [TBL] [Abstract][Full Text] [Related]
3. Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial. Dahyot-Fizelier C; Lasocki S; Kerforne T; Perrigault PF; Geeraerts T; Asehnoune K; Cinotti R; Launey Y; Cottenceau V; Laffon M; Gaillard T; Boisson M; Aleyrat C; Frasca D; Mimoz O; Lancet Respir Med; 2024 May; 12(5):375-385. PubMed ID: 38262428 [TBL] [Abstract][Full Text] [Related]
4. Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial. Liu C; Zhang YT; Peng ZY; Zhou Q; Hu B; Zhou H; Li JG Chin Med J (Engl); 2017 May; 130(10):1196-1201. PubMed ID: 28485320 [TBL] [Abstract][Full Text] [Related]
5. Respiratory therapies in the critical care setting. Should aerosolized antibiotics be administered to prevent or treat ventilator-associated pneumonia in patients who do not have cystic fibrosis? MacIntyre NR; Rubin BK Respir Care; 2007 Apr; 52(4):416-21; discussion 421-2. PubMed ID: 17417976 [TBL] [Abstract][Full Text] [Related]
6. Prophylactic antibiotic days as a predictor of sensitivity patterns in Acinetobacter pneumonia. Amin PB; Magnotti LJ; Fischer PE; Fabian TC; Croce MA Surg Infect (Larchmt); 2011 Feb; 12(1):33-8. PubMed ID: 21186957 [TBL] [Abstract][Full Text] [Related]
7. Use of Aerosolized Antibiotics in Gram-Negative Ventilator-Associated Pneumonia in Trauma Patients. Gibson BH; Sharpe JP; Lewis RH; Newell JS; Swanson JM; Wood GC; Fabian TC; Croce MA; Magnotti LJ Am Surg; 2018 Dec; 84(12):1906-1912. PubMed ID: 30606347 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of antibiotic prophylaxis against ventilator-associated pneumonia. Mirtalaei N; Farazi A; Ebrahimi Monfared M; Jokar A J Hosp Infect; 2019 Mar; 101(3):272-275. PubMed ID: 30179656 [TBL] [Abstract][Full Text] [Related]
9. Azithromycin to prevent Pseudomonas aeruginosa ventilator-associated pneumonia by inhibition of quorum sensing: a randomized controlled trial. van Delden C; Köhler T; Brunner-Ferber F; François B; Carlet J; Pechère JC Intensive Care Med; 2012 Jul; 38(7):1118-25. PubMed ID: 22527075 [TBL] [Abstract][Full Text] [Related]
10. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Palmer LB; Smaldone GC; Chen JJ; Baram D; Duan T; Monteforte M; Varela M; Tempone AK; O'Riordan T; Daroowalla F; Richman P Crit Care Med; 2008 Jul; 36(7):2008-13. PubMed ID: 18552684 [TBL] [Abstract][Full Text] [Related]
11. Prevention of early ventilation-acquired pneumonia (VAP) in comatose brain-injured patients by a single dose of ceftriaxone: PROPHY-VAP study protocol, a multicentre, randomised, double-blind, placebo-controlled trial. Dahyot-Fizelier C; Frasca D; Lasocki S; Asehnoune K; Balayn D; Guerin AL; Perrigault PF; Geeraerts T; Seguin P; Rozec B; Elaroussi D; Cottenceau V; Guyonnaud C; Mimoz O; BMJ Open; 2018 Oct; 8(10):e021488. PubMed ID: 30341115 [TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review. Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083 [TBL] [Abstract][Full Text] [Related]
14. A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia. Awad SS; Rodriguez AH; Chuang YC; Marjanek Z; Pareigis AJ; Reis G; Scheeren TW; Sánchez AS; Zhou X; Saulay M; Engelhardt M Clin Infect Dis; 2014 Jul; 59(1):51-61. PubMed ID: 24723282 [TBL] [Abstract][Full Text] [Related]
15. Effects of antibiotic prophylaxis on ventilator-associated pneumonia in severe traumatic brain injury. A post hoc analysis of two trials. Reizine F; Asehnoune K; Roquilly A; Laviolle B; Rousseau C; Arnouat M; Dahyot-Fizelier C; Seguin P J Crit Care; 2019 Apr; 50():221-226. PubMed ID: 30583121 [TBL] [Abstract][Full Text] [Related]
16. Use of aerosolized aminoglycosides in the treatment of Gram-negative ventilator-associated pneumonia. Mohr AM; Sifri ZC; Horng HS; Sadek R; Savetamal A; Hauser CJ; Livingston DH Surg Infect (Larchmt); 2007 Jun; 8(3):349-57. PubMed ID: 17635058 [TBL] [Abstract][Full Text] [Related]